Table 1. Clinicopathologic variables of PTC patients.
| Variables | Values (n=406) |
|---|---|
| Age (years) | 39.95±9.50 |
| Male | 107 (26.4) |
| Tumor size (cm) | 0.85±0.57 |
| Number of tumors | |
| Single | 286 (70.4) |
| Multiple | 120 (29.6) |
| Bilateral tumors | 75 (18.5) |
| T stage (tumor extension) | |
| I | 391 (96.3) |
| II | 14 (3.5) |
| III | 1 (0.2) |
| Capsule invasion | |
| No | 362 (89.2) |
| Yes | 44 (10.8) |
| CLNM | |
| No | 246 (60.6) |
| Yes | 160 (39.4) |
| Neutrophil (109/L) | 3.57±1.18 |
| Lymphocyte (109/L) | 1.90±0.55 |
| Monocyte (109/L) | 0.43±0.13 |
| PLT (109/L) | 227.67±63.71 |
| NLR | 2.02±0.86 |
| PLR | 126.92±41.24 |
| LMR | 4.65±1.60 |
| SII | 461.20±251.66 |
Data are expressed as mean ± standard deviation or n (%). PTC, papillary thyroid carcinoma; CLNM, central lymph node metastasis; PLT, Blood platelet; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; LMR, lymphocyte-to-monocyte ratio; SII, systemic immune-inflammation index.